Cumberland Pharmaceuticals (CPIX)
Add to Watchlists Create an Alert
4.90
+0.15 +3.16%
NASDAQ
May 24, 5:00PM
BATS Real time
Currency in USD
Cumberland Pharmaceuticals Revenue Quarterly YoY Growth:
0.02% for Dec. 31, 2012Cumberland Pharmaceuticals Historical Revenue Quarterly YoY Growth Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 0.02% |
| Dec. 31, 2012 | 5.10% |
| Sept. 30, 2012 | -4.00% |
| June 30, 2012 | -14.06% |
| March 31, 2012 | -3.85% |
| Dec. 31, 2011 | 1.69% |
| Sept. 30, 2011 | 7.08% |
| June 30, 2011 | 33.98% |
| March 31, 2011 | 5.29% |
| Dec. 31, 2010 | 19.61% |
| Sept. 30, 2010 | -10.35% |
| June 30, 2010 | 9.36% |
| March 31, 2010 | 7.72% |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
CPIX Revenue Quarterly YoY Growth Benchmarks
| Companies | |
|---|---|
| Hospira | -8.48% |
| Perrigo Company | 18.23% |
| Sagent Pharmaceuticals | 57.29% |
CPIX Revenue Quarterly YoY Growth Rankings
| Overall |
61st percentile 3084 of 8009 |
| Sector |
53rd percentile 319 of 687 in Healthcare |
| Industry |
57th percentile 29 of 69 in Drug Manufacturers - Specialty & Generic |
CPIX Revenue Quarterly YoY Growth Range, Past 5 Years
| Minimum | -14.06% | Jun 2012 |
| Maximum | 58.06% | Sep 2009 |
| Average | 10.90% |
